31
Participants
Start Date
March 28, 2019
Primary Completion Date
June 21, 2021
Study Completion Date
September 28, 2021
Infliximab
An initial period with 2 injections with infliximab allowing the determination of the primary criteria Then an extension with infliximab with 3 supplementary perfusions
Placebo
An initial period with 2 injections with placebo allowing the determination of the primary criteria Then an extension with infliximab with 5 supplementary perfusions
Hopital de la Timone- service de Médecine Internne, Marseille
CHU Hotel Dieu - service de Médecine Interne, Nantes
Hopital Claude Huriez- service de Médecine Interne, Lille
Nouvel Hopital Civil- service de Médecine Interne, Strasbourg
Hopital de la Croix Rousse- service de Médecine Interne, Lyon
GH la Pitié Salpêtrière. Service de Médecine interne, Paris
Hopital BICHAT - Médecine Interne, Paris
Hopital Bichat- service de pneumologie, Paris
Hopital Avicenne - service de pnaumologie, Bobigny
Hopital Henri Mondor- service de Médecine Interne, Créteil
Assistance Publique - Hôpitaux de Paris
OTHER